Ensol Biosciences Inc. (XKON:140610)
13,750
-150 (-1.08%)
At close: Apr 28, 2026
-45.00% (1Y)
| Market Cap | 186.26B |
| Revenue (ttm) | 537.46M |
| Net Income (ttm) | -5.40B |
| Shares Out | 13.55M |
| EPS (ttm) | -644.00 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 7,768 |
| Average Volume | 5,787 |
| Open | 13,900 |
| Previous Close | 13,900 |
| Day's Range | 13,700 - 13,900 |
| 52-Week Range | 10,350 - 38,800 |
| Beta | 0.82 |
| RSI | 44.11 |
| Earnings Date | n/a |